埃博拉病毒病幸存者视网膜纵向观察的演变
这项前瞻性观察队列研究对57名塞拉利昂埃博拉病毒病幸存者进行了为期1年的随访,评估2年后葡萄膜炎复发、暗无压力区行为及视力结局。研究发现无新发埃博拉相关视网膜病变,2名幸存者出现新发后葡萄膜炎,多数幸存者视力保持良好。
要点
- 埃博拉幸存者2年后无新发埃博拉相关视网膜病变,视力多数保持良好。
- 2名幸存者出现新发后葡萄膜炎,类似弓形虫脉络膜视网膜炎。
- 暗无压力区可扩大或消退,可能与埃博拉视网膜病变相关。
核心结论
- 埃博拉病毒病幸存者出院2年后视力维持良好。
- 暗无压力区可能提示持续的眼内刺激,或与感染病因相关。
- 治疗策略应考虑幸存者中弓形虫脉络膜视网膜炎复发的可能性。
研究设计与样本
- 前瞻性、1年观察性队列研究,2016至2017年在塞拉利昂弗里敦34军事医院进行。
- 纳入57名埃博拉病毒病幸存者,既往有眼部症状,平均年龄31.9(11.1)岁,女性37人(64.9%)。
主要发现
- 2名幸存者(3.5%)出现新发后葡萄膜炎,类似弓形虫脉络膜视网膜炎。
- 41名幸存者(73%)弓形虫IgG血清学阳性。
- 暗无压力区可局限于埃博拉视网膜病变边缘(n=7)或非埃博拉病变边缘(n=2),可累及邻近广泛视网膜区域(n=4和n=2),或孤立存在(n=6)。
- 研究期间观察到暗无压力区扩大和消退;55名幸存者(96.4%)最佳矫正视力为轻度或无视觉损害。
临床怎么用
- 对埃博拉幸存者应长期随访视网膜病变及暗无压力区变化。
- 注意筛查弓形虫脉络膜视网膜炎复发,尤其血清学阳性者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The 2-year ophthalmic sequelae of Ebola virus disease (EVD) in survivors of the 2013 to 2016 epidemic is unknown and may have public health implications for future outbreaks. OBJECTIVE: To assess the potential for uveitis recurrence, the behavior of dark without pressure, and visual outcomes in a cohort of Sierra Leonean survivors of EVD 2 years following the 2013 to 2016 Ebola epidemic. DESIGN, SETTING, AND PARTICIPANTS: Prospective, 1-year observational cohort study performed between 2016 and 2017 at 34 Military Hospital, Freetown, Sierra Leone. Participants included survivors of EVD who reported ocular symptoms since Ebola treatment unit discharge and were participants of a previous case-control study. Participants were invited for ophthalmic reexamination and finger-prick blood sampling for immunoglobulin G (IgG) to Toxoplasma gondii and HIV. EXPOSURES: Ebola virus disease. MAIN OUTCOMES AND MEASURES: Primary outcome measure: comparative ultra-widefield retinal imaging. Secondary outcome measures: visual acuity and detection of IgG to T gondii and HIV. RESULTS: Of 57 survivors of EVD who underwent repeated ophthalmic evaluation, 37 were women (64.9%). Mean (SD) age was 31.9 (11.1) years. Median interval between first and last examination was 370 days (interquartile range [IQR], 365-397.5 days), and median time from discharge to last examination was 779 days (IQR, 732-821 days). Fifteen eyes of 10 survivors (17.5%) had retinal lesions secondary to EVD. No new EVD-associated retinal lesions were observed. Two survivors (3.5%) developed new posterior uveitis resembling toxoplasmosis chorioretinitis and 41 (73%) were seropositive for T gondii IgG. Areas of dark without pressure were observed either confined to the perimeter of Ebola retinal lesions (n = 7) and non-Ebola lesions (n = 2), involving extensive retinal areas adjacent to Ebola retinal lesions (n = 4) and non-Ebola lesions (n = 2) or in isolation (n = 6). Both expansion and regression of areas of dark without pressure were observed over the study period. Best eye-presenting visual acuity had mild or no visual impairment in 55 survivors (96.4%) 2 years following discharge. CONCLUSIONS AND RELEVANCE: Vision was maintained in survivors of EVD 2 years following discharge. Evolving regions of dark without pressure may be associated with EVD retinal lesions and might suggest the presence of an ongoing intraretinal stimulus, which may be associated with infective etiology. Treatment strategies should account for the possibility of toxoplasmosis chorioretinitis recurrence within survivors of EVD.
引用
- Steptoe PJ, Momorie F, Fornah AD, et al. Evolving Longitudinal Retinal Observations in a Cohort of Survivors of Ebola Virus Disease. JAMA Ophthalmol. 2020. PMID: 32134433. doi:10.1001/jamaophthalmol.2020.0173
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。